Unlock Better Sleep: A Comprehensive Guide to Managing Insomnia

Mastering Sleep & Insomnia Management: A Comprehensive Guide

1. Introduction: The Critical Importance of Sleep and Overlooked Insomnia Diagnosis

Insomnia is a frequently overlooked diagnosis that imposes a significant global health burden. At least one in three people will experience insomnia at some point in their lives, a figure that is rising in industrialized nations. Insomnia is characterized by difficulty initiating or maintaining sleep, leading to daytime functional impairments such such as fatigue, reduced concentration, and mood disturbances. Historically, healthcare professionals have been urged to delve deeper into their patients' sleep complaints. Healthcare providers should readily integrate CBT-I (Cognitive Behavioral Therapy for Insomnia)-related interventions into their practice to reduce reliance on hypnotics and improve sleep.

2. Sleep and Health

Sleep impacts every bodily system, and insufficient sleep has detrimental effects on the immune, cardiovascular, endocrine, and nervous systems. Sleep deprivation has been shown to impair cognitive and motor function to the same degree as alcohol intoxication. Insomnia is a common predictor of cardiovascular, metabolic, neurological, and psychiatric conditions.

The Biological Clock:

• 07:30: Melatonin secretion stops
• 10:00: Peak alertness
• 12:00 (Noon): Lowest pain threshold
• 21:00: Melatonin secretion begins
• 02:00: Deepest sleep

Normal Sleep:

Sleep is a restorative process characterized by changes in brainwave activity. Sleep is primarily regulated by two rhythms:

• Circadian Rhythm: An endogenous cycle of approximately 24 hours. Influenced by melatonin and entrained by environmental "zeitgebers" such as light, temperature, and food.
• Homeostatic Sleep Drive: Determined by the accumulation of adenosine levels in the brain's prefrontal cortex. More adenosine accumulates with each waking hour, increasing the drive for sleep.

These two rhythms shape the sleep-wake cycle, while external factors like food, exercise, temperature, light, and noise also play a role. Optimizing these factors is known as 'sleep hygiene'.

Stages of Sleep:

Within the sleep-wake cycle, there's an 'Ultradian Rhythm' that repeats approximately every 90 minutes. This rhythm cycles between REM (Rapid Eye Movement) sleep and non-REM (N1, N2, N3) sleep stages.

Sleep Stage	Brainwave Activity (Hz)	Key Processes
Awake	Beta (12-30)	-
Drowsy	Alpha (8-12)	-
N1	Theta (4-10)	Easily aroused by external stimuli. Some may not feel like they've fallen asleep.
N2	Theta (4-10)	Characterized by 'K-complexes' and 'sleep spindles', which are brain responses to prevent arousal and are associated with memory.
N3	Delta (0-4)	Slow-wave sleep (SWS) occurs. The most restorative sleep stage. Blood pressure, respiratory rate, and body temperature decrease. Waking up from this stage often results in the greatest sleep inertia (drowsiness).
REM	Mixed	Strongly associated with dreaming, learning, and mood regulation. Skeletal muscles are nearly paralyzed, but brain activity is similar in intensity to wakefulness. Heart rate and blood pressure increase again. REM sleep deprivation can lead to 'REM rebound' the next day.

Sleep Changes with Age:

Even in healthy adults, sleep requirements decrease with age. Sleep duration and sleep architecture change, with increased sleep latency (time to fall asleep), more time spent in non-REM stages 1 and 2, and less time in the REM sleep stage.

3. Insomnia Disorder

Definition:

Insomnia is defined as 'difficulty initiating and/or maintaining sleep'. The International Classification of Sleep Disorders (ICSD-3) defines insomnia in three stages:

• Reported problems with sleep initiation and/or maintenance
• Despite adequate opportunity and circumstances for sleep
• Resulting in daytime consequences (fatigue, irritability, impaired concentration, etc.)

ICSD-3 classifies chronic insomnia as these symptoms occurring at least 3 times per week for 3 months or longer. Insomnia is a clinical predictor of depression regardless of duration and should be treated if it causes distress to the patient.

Spielman's Model of Insomnia:

A useful model for understanding insomnia.

• Predisposing factors: Age, disease states, lifestyle, etc., which make individuals vulnerable to insomnia.
• Precipitating factors: Bereavement, worsening illness, etc., which trigger insomnia.
• Perpetuating factors: Insomnia that persists long-term even after the original precipitating factor has resolved. This is due to cognitive and behavioral factors and is difficult to treat.

Insomnia Risk Factors:

• Older Age: Over 50% of older adults experience sleep disturbances, but this might be due to decreased sleep efficiency and unrealistic sleep expectations.
• Gender: Women are more likely to experience insomnia than men.
• Socioeconomic Factors: Unemployed individuals, those with lower education or income. Retirees and homemakers are at the highest risk.
• Relationship Status: Divorced, separated, or widowed individuals are more likely to experience insomnia, particularly among women.
• Bidirectional Relationship with Other Health Conditions: Insomnia is a risk factor for the development or worsening of chronic health conditions, which can, in turn, exacerbate insomnia. Insomnia patients have a higher prevalence of cardiovascular, gastrointestinal, and pulmonary diseases. Insomnia is also a risk factor for anxiety, depression, and increased pain perception.

Diagnosis:

Insomnia manifests with various physical and mental symptoms throughout the day and night. Similar to 'pain', insomnia has a significant psychological component.

• Sleep Diary: A common diagnostic tool, ideally kept for at least two weeks. It records bedtime, wake-up time, sleep duration, nighttime awakenings, etc. All factors that might affect sleep, such as caffeine, alcohol, meals, and smoking, should also be recorded.
• Sleep Efficiency: A useful metric calculated from the sleep diary. Sleep Efficiency = (Actual Sleep Time / Total Time in Bed) x 100. 85% indicates normal sleep, while under 50% suggests severe insomnia.
• Sleep Study: Important when other sleep disorders like sleep apnea or restless legs syndrome are suspected, or when there's a discrepancy between the patient's subjective symptoms and actual sleep patterns.

Example Questions for Insomnia Diagnosis:

• Do you have difficulty falling asleep or staying asleep?
• Does this happen most nights?
• Does it affect your daytime activities?
• Are there specific patterns or triggers? How long has this been going on?
• Do you snore heavily? (Screening for Obstructive Sleep Apnea)
• Do you have uncomfortable leg sensations relieved by movement? (Screening for Restless Legs Syndrome)
• What medications, alcohol, caffeine, or nicotine do you consume?
• Describe your average day, hour by hour.
• Do you take naps during the day?
• Would you be willing to start a sleep diary?

4. Treatment of Insomnia Disorder

Before initiating insomnia treatment, it's crucial to understand its characteristics. Mild insomnia can be effectively treated with simple advice, but if significant distress and daytime symptoms persist despite improved sleep habits, treatment should be considered.

Primary Treatment: CBT-I (Cognitive Behavioral Therapy for Insomnia)

For the long-term management of chronic insomnia, CBT-I should be offered as the first-line treatment. If CBT-I is ineffective, unavailable, or the patient urgently requires immediate sleep improvement, hypnotics should be offered alongside CBT-I.

CBT-I related advice should be provided to all insomnia patients.

• Sleep Education & Hygiene: Managing expectations about normal sleep (nighttime awakenings, reduced sleep needs with age). Advice on diet, exercise, routine, substance use (including caffeine, alcohol, nicotine), and sleep-disrupting factors in the bedroom like light, noise, and temperature.

Recommended Sleep Hygiene Habits:

• Regular moderate aerobic exercise (avoid within 4 hours of bedtime).
• Quit smoking (avoid nicotine within 6 hours of bedtime).
• Consume alcohol within recommended limits (avoid within 6 hours of bedtime).
• Increase daytime exposure to sunlight.
• Avoid large meals close to bedtime.
• Reduce caffeine intake (no caffeine after noon).
• Avoid naps and create a relaxing routine for 1 hour before bedtime.
• Use the bedroom only for sleep, sex, and dressing.
• Ensure the bedroom is dark, quiet, and at a comfortable temperature, without TV, phones, or clocks.
• Set a regular wake-up time 7 days a week, and only go to bed when sleepy.
• If you can't fall asleep within 20 minutes, leave the bedroom and engage in reading, a light snack, or a quiet activity.
• Avoid looking at the clock to check how much non-sleep time has passed.

• Stimulus Control: Techniques to strengthen the psychological association between the bed and sleep, and break the association between the bed and wakefulness. E.g., only go to bed when sleepy, leave the bed if you can't sleep, don't use the bedroom for activities other than sleep.
• Psychoeducation & Relaxation Strategies: Establishing a pre-sleep relaxation routine, such as progressive muscle relaxation and meditation, to ease physical tension and thoughts that might interfere with sleep.
• Sleep Scheduling: Setting a wake-up time and a time to get out of bed. Go to bed when you feel tired, rather than at a fixed time.
• Sleep Restriction Therapy: Controlled sleep deprivation to make the patient more efficiently fall asleep in bed. Typically involves setting an earlier wake-up time than normal and delaying bedtime until the patient feels tired. Patients might feel worse in the first few weeks, but sleep efficiency increases, and nighttime awakenings decrease. As sleep efficiency increases, bedtime is gradually moved earlier in 15-30 minute increments to restore normal nighttime sleep. Sleep should not be restricted to less than 5 hours and is contraindicated in patients with occupations involving driving, history of mental illness, seizures, or other sleep disorders like sleep apnea.
• Sleep Compression Therapy: A milder form than sleep restriction. Instead of immediate sleep restriction, the allowed time in bed is gradually increased in 30-minute increments until 85% sleep efficiency is achieved. Sleep can be compressed to a minimum of 6.5 hours.
• Cognitive Therapy: Addressing perpetuating factors of insomnia, such as irrational pre-sleep routines, and discussing paradoxical intention (the phenomenon where trying harder to sleep makes it more difficult). Patients should be encouraged not to 'try' to fall asleep.

Secondary Treatment: Pharmacological Interventions (Hypnotics)

Hypnotics are effective for short-term insomnia treatment but only provide symptomatic relief. Long-term use is not recommended.

• Benzodiazepines & Z-Drugs (GABA-PAMs): GABA-PAMs increase GABA effects, leading to hypnotic, anxiolytic, muscle relaxant, and anticonvulsant properties.
  • Temazepam: Useful for acute insomnia but can cause emotional blunting during bereavement.
  • Zolpidem, Zopiclone (Z-drugs): Useful for short-term treatment. Zolpidem has a short half-life, making it less effective for sleep maintenance problems but with less 'hangover effect' the next day.
  • Risks of Long-Term Use: Can cause increased anxiety, worsened sleep, increased fall risk, and aggravated depression.
  • Dependence: NICE recommends GABA-PAMs be used for the shortest duration possible due to their potential for misuse.
• Melatonin: Endogenous melatonin secretion decreases with age, potentially causing sleep problems. Exogenous melatonin preparations are licensed for short-term insomnia treatment in patients aged 55 and over. Melatonin's short half-life makes it more useful for sleep initiation than sleep maintenance.
• Antidepressants: Antidepressants can disrupt sleep, so they should be taken in the morning. Some antidepressants like Amitriptyline and low-dose Mirtazapine (15mg) have antihistamine effects that can cause drowsiness. However, they should not be used for insomnia as a standalone treatment but may be considered if depression or anxiety is comorbid.
• Sedating Antihistamines: Sedating antihistamines like Diphenhydramine and Promethazine play a limited role in insomnia management. Their non-selective action can lead to unwanted anticholinergic side effects such as dry mouth, urinary retention, blurred vision, dizziness, confusion, and hallucinations. They can increase the risk of falls in older adults.

Drug Comparison Table:

Drug Class	Drug	Mechanism of Action	Half-life (hours)	Comments
Benzodiazepines	Temazepam etc.	GABA Positive Allosteric Modulator	8-15	*Useful for acute insomnia.
Non-Benzodiazepines	Zopiclone, Zolpidem	GABA Positive Allosteric Modulator	2-6	Fewer side effects than benzodiazepines. Zopiclone better for sleep maintenance issues.
Antihistamines	Promethazine	Histamine (H1) Receptor	5-14	*Side effects may be underestimated, leading to over-prescription.
Melatonin Receptor Agonists	Melatonin	Pineal Gland Hormone	0.33-0.83 (20-50 minutes)	Licensed for patients 55 and over.

(*Drugs with a half-life longer than 6 hours are more likely to cause a next-day hangover effect.)

5. Key Summary

In clinical practice, there is an over-reliance on hypnotics for treating chronic insomnia. Too often, these medications are initiated without a holistic consideration of alternatives. It is common for hypnotics to be continued without thorough and timely review, perhaps to avoid conflict with patients and meet their expectations of a medical model. The appropriate use of hypnotics is essential, and when needed, these medications have therapeutic value. A careful sleep assessment is necessary to identify secondary causes of sleep disturbance.

* Data Source: Korea National Health and Nutrition Examination Survey (KNHANES), Korea Disease Control and Prevention Agency (KDCA)

* Diabetes Definition: Fasting blood glucose ≥ 126 mg/dL, HbA1c ≥ 6.5%, or physician diagnosis